However, it is interesting to note that in patients with SMA the various isoforms are present even before therapy, which confirms the fact that the SMN2 gene can produce functional proteins, although in fewer numbers than SMN1. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.